Danaher Co. (NYSE:DHR) Shares Bought by Bryn Mawr Capital Management LLC

Bryn Mawr Capital Management LLC increased its position in shares of Danaher Co. (NYSE:DHR) by 0.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 66,430 shares of the conglomerate’s stock after acquiring an additional 221 shares during the quarter. Danaher makes up about 1.0% of Bryn Mawr Capital Management LLC’s portfolio, making the stock its 21st biggest holding. Bryn Mawr Capital Management LLC’s holdings in Danaher were worth $15,368,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. Founders Financial Securities LLC acquired a new position in shares of Danaher during the 3rd quarter valued at about $218,000. GHP Investment Advisors Inc. raised its holdings in Danaher by 540.0% in the 3rd quarter. GHP Investment Advisors Inc. now owns 160 shares of the conglomerate’s stock valued at $40,000 after buying an additional 135 shares during the period. Meridian Wealth Management LLC raised its holdings in Danaher by 99.5% in the 3rd quarter. Meridian Wealth Management LLC now owns 3,264 shares of the conglomerate’s stock valued at $810,000 after buying an additional 1,628 shares during the period. Strategic Blueprint LLC raised its holdings in Danaher by 6.0% in the 3rd quarter. Strategic Blueprint LLC now owns 8,446 shares of the conglomerate’s stock valued at $2,096,000 after buying an additional 480 shares during the period. Finally, Koshinski Asset Management Inc. raised its holdings in Danaher by 16.2% in the 3rd quarter. Koshinski Asset Management Inc. now owns 1,118 shares of the conglomerate’s stock valued at $277,000 after buying an additional 156 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.3 %

DHR stock opened at $246.45 on Friday. The company’s 50 day moving average price is $248.87 and its 200 day moving average price is $231.08. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.37 and a current ratio of 1.85. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $259.00. The firm has a market capitalization of $182.54 billion, a price-to-earnings ratio of 41.77, a PEG ratio of 3.78 and a beta of 0.83.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same period in the prior year, the firm earned $2.36 earnings per share. The business’s quarterly revenue was down 2.6% compared to the same quarter last year. On average, equities research analysts anticipate that Danaher Co. will post 7.65 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Thursday, March 28th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. This is a positive change from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Wednesday, March 27th. Danaher’s dividend payout ratio is presently 18.31%.

Analysts Set New Price Targets

Several analysts recently issued reports on DHR shares. Barclays boosted their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a report on Wednesday. Citigroup boosted their price objective on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a report on Wednesday. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Royal Bank of Canada boosted their price objective on shares of Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Finally, HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and boosted their price target for the stock from $250.00 to $280.00 in a research note on Wednesday, April 17th. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $270.00.

Insider Buying and Selling

In related news, EVP Joakim Weidemanis sold 22,433 shares of the company’s stock in a transaction that occurred on Thursday, April 25th. The stock was sold at an average price of $250.46, for a total value of $5,618,569.18. Following the completion of the transaction, the executive vice president now directly owns 90,412 shares of the company’s stock, valued at $22,644,589.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Joakim Weidemanis sold 22,433 shares of the company’s stock in a transaction that occurred on Thursday, April 25th. The stock was sold at an average price of $250.46, for a total value of $5,618,569.18. Following the completion of the transaction, the executive vice president now directly owns 90,412 shares of the company’s stock, valued at $22,644,589.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Rainer Blair sold 47,175 shares of the company’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total value of $11,756,953.50. Following the completion of the transaction, the chief executive officer now directly owns 115,995 shares of the company’s stock, valued at $28,908,273.90. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 106,565 shares of company stock worth $26,641,364. Company insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.